The AMR Action Fund is a groundbreaking Venture Capital fund that enables breakthroughs in the development of antibiotics, antifungals, and other antimicrobials. We invest in companies developing innovative treatments for priority drug-resistant pathogens and advocate for market reforms and policy solutions to change how society values these lifesaving drugs.
We invest in biotechnology companies that are developing treatments for patients suffering from life-threatening antimicrobial-resistant infections.
We build partnerships to create a sustainable innovation ecosystem so that new treatments continue evolving alongside the threat of AMR.
We advocate for market reforms and policy solutions that change how society values these lifesaving drugs.
People
You last contacted this investor on .